XML 19 R4.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONSOLIDATED STATEMENT OF OPERATIONS - USD ($)
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Income Statement [Abstract]    
Sales, net $ 4,191,783 $ 2,248,341
Cost of Sales 1,644,039 873,990
Gross Profit 2,547,744 1,374,351
Costs and Expenses:    
Professional Fees 455,626 349,546
Depreciation and Amortization 499,344 470,327
Selling Expenses 704,069 380,303
Research and Development 100,321 155,984
Consulting fees 476,513 179,809
Equity Compensation Expense 1,706,393 2,564,707
General and Administrative 1,591,102 1,083,885
Total Costs and Expenses 5,533,368 5,184,561
Loss From Operations (2,985,624) (3,810,210)
Other Income (Expense):    
Amortization of Deferred Financing Costs (199,625) (342,492)
Amortization of Debt Discounts (3,996,033) (1,007,525)
Fair Value Adjustment of Derivative Liability (3,810,955) 5,936,619
Induced Conversion Costs (930,383) 0
Interest expense (253,700) (507,956)
Total Other Income (Expense) (9,190,695) 4,078,646
Net Income (Loss) $ (12,176,319) $ 268,436
Income (Loss) Per Common Share    
Basic $ (0.12) $ 0.00
Diluted $ (0.12) $ 0.00
Basic Weighted Average Common Shares Outstanding 102,840,185 81,281,030
Diluted Weighted Average Common Shares Outstanding 102,840,185 127,398,990